Synovus Financial Corp Lensar, Inc. Call Options Transaction History
Synovus Financial Corp
- $8.56 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LNSR
# of Institutions
41Shares Held
4.91MCall Options Held
700Put Options Held
31.3K-
North Run Capital, LP Wellesley, MA1.1MShares$9.19 Million7.54% of portfolio
-
Park West Asset Management LLC Larkspur, CA990KShares$8.3 Million0.37% of portfolio
-
Dimensional Fund Advisors LP Austin, TX649KShares$5.44 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA443KShares$3.72 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA433KShares$3.63 Million0.0% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $92.4M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...